Towards Healthcare
Spinal Cord Injury Treatment Market Size and Top Companies

Spinal Cord Injury Treatment Market Size Envisioned at USD 11 Billion by 2032

The report covers Spinal Cord Injury Treatment Market Size and Companies such as Acorda Therapeutics, Asterias Biotherapeutics, ReNetX Bio and others. The market is segmented by injury type into complete and partial spinal cord injuries, with treatments including corticosteroids, surgery, spinal traction and others. Hospitals, trauma centers, ambulatory surgical centers and other healthcare facilities constitute the major end users of these treatments. The report offers the value (in USD Billion) for the above segments.

Spinal Cord Injury Treatment Market Size and Growth Analysis

The spinal cord injury treatment market size achieved a value of USD 7.13 billion in 2023 and is anticipated to reach USD 11.00 billion by 2032. Projections suggest a compound annual growth rate (CAGR) of 4.8% for the period of 2024 to 2032.

Spinal Cord Injury Treatment Market Size 2023 - 2032

Unlock Infinite Advantages: Subscribe to Annual Membership

Report Highlights:

  • Complete spinal cord injuries dominated the market in 2023 with 60% market share.
  • Corticosteroids accounted for 40% market share in 2023.
  • Hospitals were largest shareholders with 60% market share in 2023.

Every year, about 18,000 new injuries to the spinal cord are reported in the United States.  This is calculated using the annual incidence rate of spinal cord injury, which is 54 per 1 million. The large number of people living with spinal cord injuries highlights the importance of ongoing efforts to prevent and treat the condition.

A spinal cord injury happens when the bundle of nerves in the spine gets hurt. This can lead to changes in feeling, movement, and strength below the injury. It can be caused by direct injury or damage to the bones around the spine. Symptoms vary based on how bad it is and where it happened. A severe injury higher up can affect most of the body, causing paralysis in limbs, while lower injuries may only affect the legs.

Spinal cord injury symptoms include numbness, tingling, or loss of sensation in hands and feet, along with paralysis, pain, or pressure in the head, neck, or back. Weakness, difficulty walking, breathing, or changes in sexual function can also occur. Motor vehicle accidents and serious falls are the top causes in the US, followed by violence, sports injuries, medical mishaps, and other accidents. Risk factors include age, alcohol use, certain diseases, and not wearing proper safety gear like seat belts or sports equipment.

In the United States, motor vehicle accidents and serious falls are the leading causes of spinal cord injuries. Other causes include acts of violence (medical errors such as gunshot wounds and assaults), sports injuries, industrial accidents, and diseases. Age is a significant factor, with individuals between 16 and 30 years old being at higher risk, as well as those over the age of 65 for dangerous falls. Alcohol use, certain medical conditions, and failure to use appropriate safety equipment like seat belts or protective gear also increase the risk of spinal cord injuries.

Older Folks are More Likely to Get Spinal Cord Injuries

According to estimates from the National Spinal Cord Injury Association, around 282,000 individuals in the United States are impacted by spinal cord injuries. Approximately 17,000 new cases of spinal cord injuries are diagnosed annually in the U.S. These figures underscore a growing need for spinal implants and devices due to the rising prevalence of SCI.

As our world progresses, we're seeing more instances of spinal cord injuries caused by different things like car accidents, falls, sports mishaps, and violent incidents. These injuries can be severe and require specialized treatment to help people recover.

As people grow older, their bodies undergo changes, and they become more susceptible to spine-related issues such as degenerative disc disease and spinal cord injuries. With the global population aging, more individuals are encountering these challenges.

Highlights of Spinal Injuries in Australia

  • Approximately 20,800 Australians have a spinal cord injury, usually caused by a traumatic event in their youth or middle age.
  • Traumatic causes, including road accidents, falls, and sports injuries, account for 81% of spinal cord injuries in individuals under 65 years old.
  • Non-traumatic causes, including tumors and degenerative disorders, are the leading cause of spinal cord injuries in individuals over 65.

As we age, the bones and discs in our spine can deteriorate or become more prone to injury. These changes can lead to conditions that affect the spinal cord. When the spinal cord is injured, it can result in difficulties with movement, sensation, and other bodily functions. Thus, with a growing older population, the demand for treatments addressing these spinal cord-related issues rises.

Treating spinal cord injuries often involves a combination of interventions. Some individuals may require surgery to repair their spine, while others may need rehabilitation to relearn movement and regain function. Due to the increasing number of older adults experiencing these problems, there's a heightened need for such treatments.

Healthcare providers and researchers are diligently working to develop new and improved methods for treating spinal cord injuries and age-related spine conditions. Their aim is to enhance the quality of life for those affected by these challenges. Through advancements in medical technology and rehabilitation techniques, they strive to provide better care and support for individuals with spinal cord injuries and related issues.

Advanced Techniques to Fix Spinal Cord Injuries and Help Those Affected

Scientists and doctors are working together like superheroes to help people with spinal cord injuries. They have special tools like advanced surgical techniques that can fix damaged spines very precisely. They also use something called neuroprosthetics, which are devices that can help people move even if their spinal cord is injured. It's like giving them a superpower to control their limbs with technology. Another tool they use is regenerative medicine, which helps the body heal itself. Scientists are learning how to use this to repair damaged spinal cords, so people can regain lost functions and live more normal lives.

Recent advancements in spinal cord injury (SCI) research, supported by the National Institute of Neurological Disorders and Stroke (NINDS), aim to improve the quality of life for people with spinal cord injuries.

Scientists are working on various approaches, including:

Electrical Stimulation System:

  •  Researchers are developing a system that uses electrical stimulation to restore hand function, postural control, and bowel and bladder control for people with spinal cord injuries. This work is funded by NINDS.

Spinal Cord Stimulation:

  • Another focus is on stimulating the spinal cord below the injury level to help preserved cells and fibers function properly. This research is also supported by NINDS.

Brain-Computer Interfaces (BCIs):

  • Experimental BCIs are being developed to allow individuals to control a computer cursor or robotic arm directly with their brains. This development is led by NINDS.

But it's not just about fixing the body; it's also about teaching it to adapt and thrive again. That's where rehabilitation methods come in. These methods help people with spinal cord injuries learn to move and function again through special exercises and therapies.

For instance,

  • In August 2023, Kaneka Corporation, a chemical company from Japan, started testing a treatment called KA-301 made from stem cells derived from human amnion (part of the placenta) on people with acute spinal cord injuries.
  • In September 2023, NervGen Pharma Corporation, a biotech company, announced that they'd given the first dose of their experimental drug NVG-291 to someone in a trial for spinal cord injuries. They're testing to see if it helps, too.
  • In October 2022, Rosies Base made a deal with SpineCraft to work together on creating better spinal implants for treating back injuries and problems. They're looking into using a special type of titanium called nanoTi in making these medical devices.

All these advancements in medical technology give hope to people with spinal cord injuries. They're not just making patients better; they're also creating more ways to treat these injuries and offering new possibilities for the future. As long as scientists keep pushing the boundaries of science, they can change many lives for the better.

Complete Spinal Cord Injuries are Life-Threatening

These injuries often result from severe trauma like car accidents or falls, causing lifelong disabilities. Due to the permanent nature of these injuries, individuals require ongoing medical care, rehabilitation, and assistive devices throughout their lives.

Percentage of Traumatic Spinal Cord Injury By Cause in Australian

This growing patient population fuels demand for various treatment options, including surgical interventions, neuroprosthetics, and regenerative medicine. Surgeons use advanced techniques to repair the spine, while neuroprosthetics offer hope by restoring some lost functions through devices like exoskeletons or nerve stimulators. Regenerative medicine explores ways to repair damaged spinal cords, potentially enabling some level of recovery for those with complete injuries. Additionally, rehabilitation plays a crucial role in helping individuals adapt to their new circumstances, improving their quality of life and independence.

Challenges Occurs Due to Limited Treatment Options

Even though medical technology has improved greatly, treating spinal cord injuries, especially when there's a complete loss of function, still has its challenges. When someone suffers a complete spinal cord injury, where they lose all sensation and movement below the injury site, current treatments mostly focus on managing symptoms and preventing further damage rather than fully restoring function. This means that while doctors can provide care to help reduce pain, manage complications, and prevent secondary issues like infections or pressure sores, they can't completely reverse the damage to the spinal cord. So, individuals with complete spinal cord injuries may not regain full movement or sensation even with the best available treatments.

This limitation is due in part to the spinal cord's complexity. It functions as a nerve superhighway, carrying messages from the brain to the rest of the body. When it is injured, the connection between the brain's neurons and the body is disrupted, making it difficult for signals to pass. Another issue is that cells in the spinal cord do not repair themselves as readily as cell in other part of the body. So, while doctors can use various therapies such as surgery, medications, or physical therapy to help, they cannot always completely restore the damaged nerves.

Researchers are continuously working to find new treatments that could help repair the spinal cord and restore function, but it's a complex puzzle that hasn't been fully solved yet. Until then, the focus remains on providing the best possible care to manage symptoms, prevent complications, and improve the quality of life for individuals living with complete spinal cord injuries.

Geographical Landscape

North America is a big hub for treating spinal cord injuries. In this hub, there are different areas where people work to help those with spinal cord injuries. some areas like the United States and Canada, have a lot of resources and facilities for treating this injury. They have hospitals, clinics, and research centers where doctors and scientists are working hard to find new treatments and therapies. As the prevalence of spinal injuries increases in the United States, it drives the growth of the spinal cord injury treatment market.

The geographical landscape for spinal cord injury treatment in Asia Pacific looks at how treatments for spinal cord injuries are spread out across countries like China, Japan, India, and Australia. It involves analyzing factors such as the quality and accessibility of healthcare infrastructure, including hospitals and rehabilitation centers. Regulations also play a significant role, as different countries may have varying approval processes for new treatments or medical devices. The availability of medical professionals trained in treating spinal cord injuries is crucial. Cultural attitudes towards disabilities and healthcare may impact the availability and acceptance of treatment.

Australian, % of Total Cases in Under or Over 65 Group, 2020 Estimates

Competitive Landscape

Pharmaceutical companies develop drugs to alleviate symptoms, reduce inflammation, or promote neuroprotective or aerogeneration after spinal cord injury patients. Companies offer innovative rehabilitation devices, robotics, and assistive technologies to enhance mobility and function for spinal cord injury patients. Also, the manufacturer of spinal cord stimulators and other neurostimulation devices aimed at managing pain and improving function in spinal cord injury patients. Providers of imaging technologies and diagnostic tools for accurate assessment and monitoring of spinal cord injuries.

Recent Developments

  • In July 2023, NeuroSolv Therapeutics, an ethical business based in Belfast, Northern Ireland, and Baltimore, United States, and AscellaHealth LLC, a global healthcare and specialty pharmacy solutions company that serves individuals, life sciences manufacturers, payers, and providers, announced a collaboration to expand clinical trial development and accelerate regulatory approval procedures to maximize the prospect of bringing Perineline to market.
  • In July 2021, the United States Food and Drug Administration (FDA) granted Mitsubishi Tanabe Pharma Corporation, an international pharmaceutical company, fast-track designation for MT-3921 for the treatment of spinal cord injuries.
  • In September 2020, AbbVie announced that elezanumab (ABT-555), an investigation treatment for spinal cord injury, received Orphan Drug and Fast Track designations from the FDA.

Spinal Cord Injury Treatment Market Companies

  • Acorda Therapeutics, Inc.
  • Asterias Biotherapeutics
  • ReNetX Bio.
  • BioArctic AB
  • BioTime, Inc.
  • InVivo Therapeutics
  • Kringle Pharma, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Pharmicell Co. Ltd.

Spinal Cord Injury Treatment Market Segments

By Injury Type

  • Complete Spinal Cord Injuries
  • Partial Spinal Cord Injuries

By Treatment

  • Corticosteroid
  • Surgery
  • Spinal Traction
  • Others

By End User

  • Hospital
  • Trauma Centers
  • Ambulatory Surgical Centers
  • Others

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • South America

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500

About The Author

Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.

FAQ's

Symptoms of spinal cord injury may include loss of sensation or movement, difficulty breathing, muscle weakness, and loss of bowel or bladder control.

The driving factors affecting the spinal cord injury treatment market include demographic shifts such as aging populations, and ongoing innovations in medical technology and rehabilitation techniques.

The hurdles of the spinal cord injury treatment market include limited treatment options, financial constraints, and the complexity of regenerating nerve tissue.

World Health Organization, Food and Drug Administration, National Institute of Health, MedlinePlus.gov and Treasury.gov.au.